Price to Book Value Chart

View Price to Book Value for PRGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
September 22, 2026 0.7889
September 21, 2026 0.779
September 18, 2026 0.7476
September 17, 2026 0.7432
September 16, 2026 0.7465
September 15, 2026 0.7476
September 14, 2026 0.7525
September 11, 2026 0.7531
September 10, 2026 0.7492
September 09, 2026 0.7906
September 08, 2026 0.8038
September 04, 2026 0.8226
September 03, 2026 0.7867
September 02, 2026 0.7989
September 01, 2026 0.7955
August 31, 2026 0.8071
August 28, 2026 0.7983
August 27, 2026 0.7922
August 26, 2026 0.8137
August 25, 2026 0.7983
August 24, 2026 0.7867
August 21, 2026 0.7856
August 20, 2026 0.7553
August 19, 2026 0.7696
August 18, 2026 0.7151
Date Value
August 17, 2026 0.7068
August 14, 2026 0.7189
August 13, 2026 0.7073
August 12, 2026 0.6996
August 11, 2026 0.7084
August 10, 2026 0.6969
August 07, 2026 0.7079
August 06, 2026 0.6913
August 05, 2026 0.7316
August 04, 2026 0.5943
August 03, 2026 0.5888
July 31, 2026 0.5574
July 30, 2026 0.5684
July 29, 2026 0.575
July 28, 2026 0.5679
July 27, 2026 0.559
July 24, 2026 0.5563
July 23, 2026 0.5568
July 22, 2026 0.5772
July 21, 2026 0.5772
July 20, 2026 0.5838
July 17, 2026 0.591
July 16, 2026 0.6153
July 15, 2026 0.5596
July 14, 2026 0.5458

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 2.865
Corcept Therapeutics, Inc. 17.27
Veru, Inc. 1.472
Johnson & Johnson 7.630
Eli Lilly & Co. 32.03

Price to Book Value Related Metrics

PS Ratio 0.4639
PEG Ratio -0.0005
Price to Free Cash Flow 16.12
Price 13.84
Earnings Yield -90.43%
Market Cap 1.919B
PEGY Ratio -0.0005
Operating PE Ratio 7.226